The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Analysis and interpretation of cost data in randomised controlled trials: review of published studies
Open accessAbstract
OBJECTIVE: To review critically the statistical methods used for health economic evaluations in randomised controlled trials where an estimate of cost is available for each patient in the study. DESIGN: Survey of published randomised trials including an economic evaluation with cost values suitable for statistical analysis; 45 such trials published in 1995 were identified from Medline. MAIN OUTCOME MEASURES: The use of statistical methods for cost data was assessed in terms of the descriptive statistics reported, use of statistical inference, and whether the reported conclusions were justified. RESULTS: Although all 45 trials reviewed apparently had cost data for each patient, only 9 (20%) reported adequate measures of variability for these data and only 25 (56%) gave results of statistical tests or a measure of precision for the comparison of costs between the randomised groups. Only 16 (36%) of the articles gave conclusions which were justified on the basis of results presented in the paper. No paper reported sample size calculations for costs. CONCLUSIONS: The analysis and interpretation of cost data from published trials reveal a lack of statistical awareness. Strong and potentially misleading conclusions about the relative costs of alternative therapies have often been reported in the absence of supporting statistical evidence. Improvements in the analysis and reporting of health economic assessments are urgently required. Health economic guidelines need to be revised to incorporate more detailed statistical advice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Practical Statistics for Medical Research.
Walter, S. D., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,668
Practical Statistics for Medical Research
Altman, D. G. (1990) · doi:10.1201/9780429258589 · Cited by 10,668
Practical Statistics for Medical Research.
Bartko, J. J., & Altman, D. G. (1992) · Journal of the American Statistical Association · doi:10.2307/2290246 · Cited by 4,797
Systematic Reviews: Identifying relevant studies for systematic reviews
Dickersin, K., Scherer, R., & Lefebvre, C. (1994) · BMJ · doi:10.1136/bmj.309.6964.1286 · Cited by 2,256
Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, M. F., & Jefferson, T. O. (1996) · BMJ · doi:10.1136/bmj.313.7052.275 · Cited by 1,827
Statistical guidelines for contributors to medical journals.
Altman, D. G., Gore, S. M., Gardner, M. J., & Pocock, S. J. (1983) · BMJ · doi:10.1136/bmj.286.6376.1489 · Cited by 661
Modelling in Ecomomic Evaluation: An Unavoidable Fact of Life
Buxton, M. J., Drummond, M. F., Van Hout, B. A., Prince, R. L., Sheldon, T. A., Szucs, T., & Vray, M. (1997) · Health Economics · doi:10.1002/(sici)1099-1050(199705)6:3<217::aid-hec267>3.0.co;2-w · Cited by 595
Udvarhelyi, I. S., Colditz, G. A., Rai, A., & Epstein, A. M. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-3-238 · Cited by 413
Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues
Drummond, M. F., & Davies, L. (1991) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300007121 · Cited by 337
ESTIMATING CONFIDENCE INTERVALS FOR COST-EFFECTIVENESS RATIOS: AN EXAMPLE FROM A RANDOMIZED TRIAL
CHAUDHARY, M. A., & STEARNS, S. C. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19960715)15:13<1447::aid-sim267>3.0.co;2-v · Cited by 313
Economic Analysis in Randomized Control Trials
Adams, M. E., McCall, N. T., Gray, D. T., Orza, M. J., & Chalmers, T. C. (1992) · Medical Care · doi:10.1097/00005650-199203000-00005 · Cited by 188
Rowley, M. J., Hensley, M. J., Brinsmead, M. W., & Wlodarczyk, J. H. (1995) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1995.tb124592.x · Cited by 183
Hooton, T. M. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520250057034 · Cited by 182
Identifying relevant studies for systematic reviews
Clarke, M., & Greaves, L. (1995) · BMJ · doi:10.1136/bmj.310.6981.741a · Cited by 174
Hill, A. B. (1953) · New England Journal of Medicine · doi:10.1056/nejm195306112482401 · Cited by 174
Health Care CBA/CEA: An Update on the Growth and Composition of the Literature
Elixhauser, A., Luce, B. R., Taylor, W. R., & Reblando, J. (1993) · Medical Care · doi:10.1097/00005650-199307001-00001 · Cited by 165
Cost-utility in practice: A policy maker's guide to the state of the art
Gerard, K. (1992) · Health Policy · doi:10.1016/0168-8510(92)90022-4 · Cited by 141
Economic analysis and clinical trials
Drummond, M., & Stoddart, G. L. (1984) · Controlled Clinical Trials · doi:10.1016/0197-2456(84)90118-1 · Cited by 132
Methods for Comparison of Cost Data
Zhou, X., Melfi, C. A., & Hui, S. L. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00063 · Cited by 129
Sensitivity analysis in economic evaluation: A review of published studies
Briggs, A. H., & Sculpher, M. J. (1995) · Health Economics · doi:10.1002/hec.4730040502 · Cited by 122
Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials?
O'Brien, B. (1996) · PubMed · Cited by 116
Transfer of Technology From Statistical Journals to the Biomedical Literature
Altman, D. G. (1994) · JAMA · doi:10.1001/jama.272.2.129 · Cited by 103
The Lancet's statistical review process: areas for improvement by authors
Gore, S. M., Jones, G., & Thompson, S. G. (1992) · The Lancet · doi:10.1016/0140-6736(92)90409-v · Cited by 88
Self-citationLambert, C., Hurst, N. P., Forbes, J., Lochhead, A., Macleod, M., & Nuki, G. (1998) · BMJ · doi:10.1136/bmj.316.7136.965 · Cited by 79
Reporting guidelines for economic studies
Mason, J. M., & Drummond, M. (1995) · Health Economics · doi:10.1002/hec.4730040202 · Cited by 73
Evaluating the BMJ Guidelines for Economic Submissions
Jefferson, T., Smith, R., Yee, Y., Drummond, M., Pratt, M., & Gale, R. (1998) · JAMA · doi:10.1001/jama.280.3.275 · Cited by 72
Generalisation from phase III clinical trials: survival, quality of life, and health economics
Fayers, P. M., & Hand, D. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03053-5 · Cited by 68
Economic Evaluation of Mental Health Care Interventions. A Review
Evers, S., Wijk, A., & Ament, A. J. H. A. (1997) · Health Economics · Cited by 66
Is vaccination against hepatitis b efficient? A review of world literature
Jefferson, T., & Demicheli, V. (1994) · Health Economics · doi:10.1002/hec.4730030105 · Cited by 58
Statistical Analysis in Pharmacoeconomic Studies
Coyle, D. (1996) · PharmacoEconomics · doi:10.2165/00019053-199609060-00005 · Cited by 54
Cost and Efficacy of the Substitution of Ambulatory for Inpatient Care
Berk, A. A., & Chalmers, T. C. (1981) · New England Journal of Medicine · doi:10.1056/nejm198102123040704 · Cited by 50
Statistical guidelines for contributors to medical journals
Altman, D. G., Gore, S. M., Gardner, M. J., & Pocock, S. (1983) · BMJ · doi:10.1136/bmj.287.6385.132-a · Cited by 47
Cottrell, J. J., Openbrier, D. R., Lave, J. R., Paul, C., & Garland, J. L. (1995) · CHEST Journal · doi:10.1378/chest.107.2.358 · Cited by 22
Siegelman, S. S. (1988) · Radiology · doi:10.1148/radiology.166.1.3336695 · Cited by 20
Boland, C. (1996) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1996.tb124825.x · Cited by 9
Gotlib, A. (1986) · Europe PMC (PubMed Central) · Cited by 6
From efficacy to cost-effectiveness
Thompson, S. G., & Barber, J. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63615-x · Cited by 3
Self-citation
Cited by
Early versus late parenteral nutrition in critically ill adults
Casaer, M. P., Mesotten, D., Hermans, G., Wouters, P. J., Schetz, M., Meyfroidt, G., Van Cromphaut, S., Ingels, C., Meersseman, P., Muller, J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102662 · Cited by 1,696
Ramsey, S. D., Willke, R. J., Glick, H., Reed, S. D., Augustovski, F., Jonsson, B., Briggs, A., & Sullivan, S. D. (2015) · Value in Health · doi:10.1016/j.jval.2015.02.001 · Cited by 811
How should cost data in pragmatic randomised trials be analysed?
Thompson, S. G. (2000) · BMJ · doi:10.1136/bmj.320.7243.1197 · Cited by 772
Self-citationRamsey, S., Willke, R., Briggs, A., Brown, R., Buxton, M., Chawla, A., Cook, J., Glick, H., Liljas, B., Petitti, D., et al. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.00045.x · Cited by 720
Analysis of cost data in randomized trials: an application of the non-parametric bootstrap
Barber, J. A., & Thompson, S. G. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20001215)19:23<3219::aid-sim623>3.0.co;2-p · Cited by 690
Self-citation
Metadata
- Authors
- Barber, J. A., & Thompson, S. G.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1998-10-31
- Volume
- 317
- Issue
- 7167
- Pages
- 1195-1200
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2140354297
- Cited by
- 254
- References
- 39
- FWCI
- 44.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.